Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: ZOLEDRONATE, . Treffer: 6
2023
Beltran-Bless, AA; Clemons, MJ; Fesl, C; Greil, R; Pond, GR; Balic, M; Vandermeer, L; Bjelic-Radisic, V; Singer, CF; Steger, GG; Helfgott, R; Egle, D; Solkner, L; Gampenrieder, SP; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Rinnerthaler, G; Pfeiler, G; Fohler, H; Hlauschek, D; Hilton, J; Gnant, M
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
EUR J CANCER. 2023; 180: 108-116.
Doi: 10.1016/j.ejca.2022.12.003
Web of Science
PubMed
FullText
FullText_MUG
2019
Trapp, E; Janni, W; Schindlbeck, C; Jückstock, J; Andergassen, U; de Gregorio, A; Alunni-Fabbroni, M; Tzschaschel, M; Polasik, A; Koch, JG; Friedl, TWP; Fasching, PA; Haeberle, L; Fehm, T; Schneeweiss, A; Beckmann, MW; Pantel, K; Mueller, V; Rack, B; Scholz, C; SUCCESS Study Group
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
J Natl Cancer Inst. 2019; 111(4):380-387
Doi: 10.1093/jnci/djy152
Web of Science
PubMed
FullText
FullText_MUG
2017
Fung, P; Bedogni, G; Bedogni, A; Petrie, A; Porter, S; Campisi, G; Bagan, J; Fusco, V; Saia, G; Acham, S; Musto, P; Petrucci, MT; Diz, P; Colella, G; Mignogna, MD; Pentenero, M; Arduino, P; Lodi, G; Maiorana, C; Manfredi, M; Hallberg, P; Wadelius, M; Takaoka, K; Leung, YY; Bonacina, R; Schiødt, M; Lakatos, P; Taylor, T; De Riu, G; Favini, G; Rogers, SN; Pirmohamed, M; Nicoletti, P; GENVABO Consortium; Fedele, S
Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Oral Dis. 2017; 23(4):477-483
Doi: 10.1111/odi.12632
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Rack, B; Jückstock, J; Trapp, E; Weissenbacher, T; Alunni-Fabbroni, M; Schramm, A; Widschwendter, P; Lato, K; Zwingers, T; Lorenz, R; Tesch, H; Schneeweiss, A; Fasching, P; Mahner, S; Beckmann, MW; Lichtenegger, W; Janni, W; SUCCESS Study Group
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Tumour Biol. 2016; 37(10):13769-13775
Doi: 10.1007/s13277-016-5171-2
Web of Science
PubMed
FullText
FullText_MUG
2014
Rugani, P; Luschin, G; Jakse, N; Kirnbauer, B; Lang, U; Acham, S
Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer.
Clin Oral Investig. 2014; 18(2):401-407
Doi: 10.1007/s00784-013-1012-5
Web of Science
PubMed
FullText
FullText_MUG
2010
Dimai, HP; Pietschmann, P; Resch, H; Preisinger, E; Fahrleitner-Pammer, A; Dobnig, H; Klaushofer, K; Austrian Society for Bone and Mineral Research (AuSBMR)
Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
Wien Med Wochenschr. 2010; 160(21-22):586-589
Doi: 10.1007/s10354-010-0840-z
PubMed
FullText
FullText_MUG